New NIST Standard Helps Deliver the Right Dosage of Cancer-Fighting Drugs
June 04, 2025
June 04, 2025
WASHINGTON, June 4 -- The U.S. Department of Commerce's National Institute of Standards and Technology issued the following news:
* * *
New NIST Standard Helps Deliver the Right Dosage of Cancer-Fighting Drugs
* New drugs based on the radioactive isotope actinium-225 show promise in clinical trials for fighting prostate cancer, neuroendocrine tumors and certain forms of leukemia.
* These drugs must contain the right amount of radioactivity . . .
* * *
New NIST Standard Helps Deliver the Right Dosage of Cancer-Fighting Drugs
* New drugs based on the radioactive isotope actinium-225 show promise in clinical trials for fighting prostate cancer, neuroendocrine tumors and certain forms of leukemia.
* These drugs must contain the right amount of radioactivity . . .